|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||1.41 / 3.37|
We scaled into one position during a week dominated by Hurricane Harvey and its aftermath.
We initiated 2 small positions last week as the market moved higher.
Investors considering a purchase of Antares Pharma Inc. shares, but tentative about paying the going market price of $3.06/share, might benefit from considering selling puts among the alternative strategies at their disposal.
North Korea puts a worrying wrinkle in the markets. We add to 2 portfolio positions.
Five portfolio names report today. Here is what we have seen, and what two expect after the closing bell.
Revenue of $13.4 Million and Net Loss Per Share of $0.02
We made several trades and price target changes during a mixed week for the portfolio.
The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.
We brought a new name into the portfolio last week as the Fed's comments helped lift the market.
We made no trades during the holiday-shortened week, but added to our natural hedge today.
We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.
We exited 2 positions and took some profits during a busy week for the portfolio.
We initiated a new position and made several other trades during a week of twists and turns.
We initiated 2 new positions in a week dominated by political events.
Five Year Term Loan Agreement Provides Up To $35 Million
Investors in Antares Pharma Inc. saw new options begin trading this week, for the July 21st expiration.
It was a busy week of moves in the portfolio as we head into the latter half of the second quarter.
We initiated one new position and exited another last week, while several other names reported earnings.
BETR and ATRS report March-quarter numbers. Plus, post-call commentary on USA Technologies.
Multiple Drug Device Combination Products Pending FDA Approval
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.